3 -deazapurine derivatives as tlr7 modulators

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2640672

The present invention relates to immune response modifiers of Formula (I), which act selectively through agonism, of Toll-Like Receptors (TLRs), uses thereof, processes for the preparation thereof, intermediates used in the preparation thereof and compositions containing said inhibitors. These inhibitors have utility in a variety of therapeutic areas including the treatment of infectious disease such as Hepatitis (e.g. HCV, HBV), genetically related viral infection and cancer.

La présente invention concerne des agents modifiant la réponse immunitaire de formule (I), qui agissent sélectivement par agonisme des récepteurs analogues à Toll (TLR, Toll-like receptor), leurs utilisations, des procédés pour les préparer, des intermédiaires utilisés pour les préparer et des compositions contenant lesdits inhibiteurs. Ces inhibiteurs sont utiles dans divers domaines thérapeutiques, parmi lesquels le traitement d'une maladie infectieuse telle que l'hépatite (par exemple HCV, HBV), une infection par un virus génétiquement apparenté et le cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

3 -deazapurine derivatives as tlr7 modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3 -deazapurine derivatives as tlr7 modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3 -deazapurine derivatives as tlr7 modulators will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1413063

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.